Page last updated: 2024-09-05

sb 203580 and trientine

sb 203580 has been researched along with trientine in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(trientine)
Trials
(trientine)
Recent Studies (post-2010) (trientine)
3,48941,13745012158

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
ENDOH, D; HAYASHI, M; KADOWAKI, S; OKUI, T1

Other Studies

1 other study(ies) available for sb 203580 and trientine

ArticleYear
Trientine, a copper-chelating agent, induced apoptosis in murine fibrosarcoma cells by activation of the p38 MAPK pathway.
    The Journal of veterinary medical science, 2009, Volume: 71, Issue:11

    Topics: Animals; Apoptosis; Cell Line, Tumor; Chelating Agents; Copper; Enzyme Activation; Fibrosarcoma; Imidazoles; Mice; p38 Mitogen-Activated Protein Kinases; Pyridines; Signal Transduction; Trientine

2009